Dow Jones Giant Merck Inks A New Deal In Lung Cancer — And Shares Pop

Dow Jones Giant Merck Inks A New Deal In Lung Cancer — And Shares Pop

Novocure and Dow Jones pharmaceutical giant Merck announced a collaboration in non-small cell lung cancer treatment Wednesday — prodding shares of Novocure and Merck stock to pop.